DDrare: Database of Drug Development for Rare Diseases

Mesalazine slow-release granules (DrugBank: Mesalazine)

4 diseases

ID	Disease name (Link within this page)	Number of trials
46	Malignant rheumatoid arthritis	0
96	Crohn disease	0
97	Ulcerative colitis	1
164	Oculocutaneous albinism	0

46. Malignant rheumatoid arthritis [ 4,183 clinical trials, 2,538 drugs, (DrugBank: 401 drugs), 183 drug target genes, 219 drug target pathways]

Searched query = "Malignant rheumatoid arthritis", "Rheumatoid arthritis", "Rheumatoid arthritis with vasculitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 4,183 trial found

96. Crohn disease [ 2,209 clinical trials, 1,276 drugs, (DrugBank: 240 drugs), 166 drug target genes, 210 drug target pathways]

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 2,209 trial found

97. Ulcerative colitis [ 2,269 clinical trials, 1,331 drugs, (DrugBank: 241 drugs), 114 drug target genes, 181 drug target pathways]

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 2,269 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00737789 (ClinicalTrials.gov)	November 2008	19/8/2008	Mesalazine 4g Once Daily Versus 4g in Two Divided Doses in Active Ulcerative Colitis.	Multicentre, Controlled, Randomised, Investigator-Blinded, Comparative Study of Oral Mesalazine 4g Once Daily Versus Mesalazine 4g in Two Divided Doses in Patients With Active Ulcerative Colitis.	Ulcerative Colitis	Drug: Mesalazine slow-release granules;Drug: Mesalazine liquid enema	Ferring Pharmaceuticals	NULL	Completed	18 Years	N/A	Both	206	Phase 3	Belgium;France;Netherlands;United Kingdom

164. Oculocutaneous albinism [ 15 clinical trials, 57 drugs, (DrugBank: 34 drugs), 34 drug target genes, 136 drug target pathways]

Searched query = "Oculocutaneous albinism", "Hermansky-Pudlak syndrome", "Chediak-Higashi syndrome", "Griscelli syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 15 trial found